References

• 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
• 2019RoB 2: a revised tool for assessing risk of bias in randomised trials33,067 cited
• 2009The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration28,094 cited
• 2000Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting20,612 cited
• 2016ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions20,225 cited
• 2019Cochrane Handbook for Systematic Reviews of Interventions14,763 cited
• 2017AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both10,605 cited
• 1999Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement4,828 cited
• 2007Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews4,376 cited
• 2021PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews3,654 cited
• 1998Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?3,560 cited
• 2016The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses1,481 cited
• 1987Meta-Analyses of Randomized Controlled Trials